A new Australian study has uncovered an intriguing link between an iron-related gene variant and a higher risk of dementia in men. The research shows that men carrying two copies of the common H63D variant are more than twice as likely to develop dementia, while women with the same variant remain largely unaffected. 🔍
The study analyzed data from over 19,000 participants in the ASPREE trial, a major international effort focused on healthy aging. Researchers from Curtin University, Monash University, and the University of Melbourne found that while one in three people have a single copy of the variant (with no health impact), one in 36 carries two copies. For men, this double variant significantly ramps up the dementia risk.
Co-author Prof. John Olynyk noted, "Having just one copy of this gene variant does not impact someone's health. However, having two copies more than doubles the risk in men." This discovery shines a light on the importance of personalized health strategies, not only for dementia prevention but also for early intervention and treatment. 🧠
For our tech-savvy and socially conscious readers from South and Southeast Asia, this research highlights how genetics can influence health outcomes. It’s a reminder that even factors we cannot change, like our genes, can lead to innovative approaches in healthcare. Imagine using cutting-edge technology and data to tailor preventive care, a goal that resonates with many young professionals exploring the intersection of technology and wellness.
With over 400,000 Australians currently living with dementia—many of them men—this study could pave the way for more targeted prevention strategies worldwide. As our communities in cities like Mumbai, Jakarta, and Manila continue to embrace technology and global trends, research like this offers a glimpse into a future where personalized health care is within reach.
Reference(s):
Iron-related gene variant tied to higher dementia risk in men: study
cgtn.com
